Dysphagia Knowledge Hub — 吞嚥困難知識庫

Dysphagia in ALS/MND: Progressive Management from Early to Late Stage

Amyotrophic lateral sclerosis (ALS) — known in many Commonwealth countries as motor neurone disease (MND) — is a progressive neurodegenerative condition that systematically destroys the motor neurons controlling voluntary movement, including every muscle involved in swallowing. Unlike stroke-related dysphagia, which frequently improves with rehabilitation, dysphagia in ALS follows an irreversible trajectory that requires not just reactive management but proactive, anticipatory planning across a changing clinical picture.

This guide outlines how swallowing changes across the stages of ALS, how to plan ahead rather than wait for a crisis, and the specific decisions — including gastrostomy timing — that the multidisciplinary team and patient need to navigate together.

How ALS Affects Swallowing

ALS damages both upper motor neurons (UMN) in the motor cortex and lower motor neurons (LMN) in the brainstem and spinal cord. Swallowing is controlled by LMN pathways through cranial nerves V, VII, IX, X, and XII. When these are affected — a pattern called bulbar involvement — swallowing, speech, and breathing are all compromised.

Bulbar-onset ALS (approximately 25–30% of patients) presents first with dysarthria (slurred speech), dysphagia, and sialorrhoea (drooling due to reduced swallowing frequency). These patients experience dysphagia earlier and more severely.

Limb-onset ALS (approximately 70%) typically develops dysphagia later, but bulbar involvement eventually occurs in nearly all patients as the disease progresses.

The specific swallowing deficits in ALS include:

These deficits compound each other as the disease progresses. A patient who initially manages with a soft diet may, within months, require puréed food and thickened liquids; within a year, oral intake may become unsafe.

Early Stage: Proactive Planning While Intake Is Still Safe

The most important principle in ALS dysphagia management is to begin planning when swallowing is still relatively preserved. This is counterintuitive — it can feel unnecessary to discuss gastrostomy or texture modification when someone is still eating a near-normal diet. But in ALS, respiratory function and weight status decline in parallel with swallowing. Waiting until a crisis (acute weight loss, aspiration pneumonia, or severe respiratory compromise) narrows every available option.

Early SLT referral: All patients newly diagnosed with ALS should be referred to a speech-language therapist for baseline swallowing assessment, even if swallowing is currently unaffected. This establishes a baseline and creates a relationship before the need becomes urgent.

Dietary energy density: ALS significantly increases caloric expenditure through muscle fasciculations and compensatory effort. Dietitian input from the early stage is essential to ensure adequate energy intake — typically 35–45 kcal/kg/day is targeted. High-calorie, high-protein foods are prioritised within the texture modifications that are required.

Early IDDSI progression: The SLT will guide a stepwise transition through IDDSI levels as needed:

Each transition should be planned ahead of the point at which the previous level becomes unsafe.

Pacing and fatigue: Meal duration should be monitored. When swallowing requires progressively more effort, fatigue during meals causes aspiration risk to increase towards the end of the meal. Smaller, more frequent meals may be recommended. Rest before meals is often advised.

Sialorrhoea management: Pooling of saliva becomes a significant aspiration risk as swallowing frequency declines. Anticholinergic medications (hyoscine patches, amitriptyline in low doses, glycopyrronium bromide) can reduce saliva production. Botulinum toxin injection into the salivary glands is available at specialist centres for refractory cases. This is an area where proactive referral to neurology prevents a distressing and dangerous symptom from going unmanaged.

The PEG Decision: Timing Is Critical

Percutaneous endoscopic gastrostomy (PEG) is the primary method of enteral nutritional support in ALS when oral intake becomes insufficient or unsafe. A PEG is a flexible tube placed directly through the abdominal wall into the stomach under endoscopic guidance, allowing formula feeds and medications to be delivered without swallowing.

Why timing matters: PEG insertion requires conscious sedation and involves procedural respiratory demand. As ALS progresses, respiratory muscle weakness reduces the safety margin for this procedure. The internationally accepted threshold — supported by NICE (UK), EFNS guidelines, and the ALS Association — is:

PEG should be placed before forced vital capacity (FVC) drops below 50% of predicted.

Below this threshold, respiratory complications during and after PEG insertion increase significantly. In practice, the procedure should ideally be planned when FVC is still above 60–65% to allow time for investigation and scheduling. In patients where FVC is already declining rapidly, earlier discussion is warranted.

Radiologically inserted gastrostomy (RIG): For patients who present with FVC already below 50% or who are poor candidates for conventional PEG, RIG — inserted under X-ray guidance without endoscopic sedation — carries a lower respiratory burden. Availability varies across Hong Kong centres.

The conversation with the neurologist and SLT: The decision to proceed with PEG should be made in an advance discussion, not under crisis conditions. The discussion should include:

In many cases in Hong Kong, this conversation happens through the neurology clinic with SLT, dietitian, and palliative care input. Public hospitals with ALS or neuromuscular disease clinics — including Queen Mary Hospital and Prince of Wales Hospital — typically coordinate this planning through multidisciplinary clinics.

PEG does not mean the end of oral eating: Where aspiration risk is manageable and the patient wishes to continue eating for pleasure, oral intake may continue alongside PEG feeding. The PEG carries the nutritional burden; the mouth continues to provide quality-of-life benefit. This distinction is important and should be explicitly communicated to patients and families.

Mid Stage: Balancing Nutrition and Quality of Life

As the disease progresses and oral intake becomes more restricted, the focus shifts from restoration to comfort and safety.

Thickened fluids and palatability: Many patients and families find thickened liquids unpleasant. The degree of thickening should be the minimum that provides acceptable safety, not the maximum. FEES or VFSS can be used to find this minimum and to reassess as the clinical picture changes.

Swallowing compensatory strategies: Despite the progressive nature of ALS, compensatory techniques remain useful for extending the period of safe oral intake:

Respiratory-feeding coordination: As respiratory muscle weakness progresses, the coordination between breathing and swallowing — which must be precise to prevent aspiration — is disrupted. NIV (non-invasive ventilation, typically BiPAP) is increasingly used in ALS for respiratory support. Meal timing in relation to NIV sessions should be planned; many patients find eating easier when respiratory function is better supported in the morning or after a period of NIV use. The SLT and respiratory physician should coordinate on this.

Late Stage: Comfort, Dignity, and Advance Care Planning

In advanced ALS, when PEG feeding is providing primary nutrition and swallowing is severely compromised, the clinical emphasis shifts to comfort and quality of life.

Comfort feeding: The option to continue small quantities of pleasurable foods — flavours the patient enjoys, regardless of IDDSI level — is available to most patients even when safe oral nutrition is no longer possible. Comfort feeding requires careful positioning, small volumes, and acceptance that some aspiration may occur. This is a values-based decision that should be made by the patient (or their designated decision-maker) with full information.

Oral hygiene: Meticulous oral care becomes especially important when swallowing of saliva is reduced and pooled secretions are aspirated continuously. Twice-daily gentle toothbrushing, regular moistening of the oral mucosa, and suctioning of excess secretions where available reduce infection risk.

Advance care planning: The ALS clinical team should initiate advance care planning discussions early — ideally in the first year of diagnosis. Hong Kong’s legal framework for advance directives (under the Mental Health Ordinance) allows patients with capacity to document their wishes regarding resuscitation, ventilation, and artificial nutrition. Engaging with this framework while the patient has full communicative capacity avoids the much more difficult situation of surrogate decision-making under crisis conditions.

Hong Kong Resources

HK MND Association (香港運動神經元病協會): Provides peer support, caregiver guidance, patient advocacy, and links to HA neurology services. Contact through their website or via the neurology social work team at major public hospitals.

Hospital Authority neurology clinics: Queen Mary Hospital (neuromuscular disease clinic), Prince of Wales Hospital, and Tuen Mun Hospital all offer multidisciplinary ALS care including SLT, dietitian, physiotherapy, occupational therapy, respiratory medicine, and palliative care involvement.

Palliative care integration: Early referral to palliative care — which in Hong Kong includes Hospital Authority’s palliative care units and community palliative care teams — is increasingly recognised as beneficial from the point of diagnosis, not just in the terminal phase. Palliative care specialists can help with symptom management (secretions, anxiety, pain) and with advance care planning discussions that sit outside the scope of neurology and SLT.

Key Takeaway

Dysphagia in ALS is not a complication to be managed reactively — it is a predictable and central feature of the disease that must be planned for ahead of each transition. The window for safe PEG insertion closes as respiratory function declines. The window for meaningful advance care planning closes as communication becomes more difficult. Beginning these conversations early, maintaining regular SLT and dietitian review, and staying ahead of each clinical threshold are the foundations of good ALS swallowing management.